Crinetics Pharmaceuticals, Inc. Investing Cash Flow
Crinetics Pharmaceuticals, Inc. (CRNX) reported Investing Cash Flow of -$226.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $26.29M, a 30.72% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$252.36M.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $57.11M.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $164.81M, a 699.93% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $173.91M.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$574.82M.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$200.41M.
- Crinetics Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$173.98M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$226.07M 10-Q · filed 2026-08-03 | -$168.96M derived: sum of 3 quarters · filed 2026-08-03 | -$4.15M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$252.36M 10-Q · filed 2026-05-07 | -$195.25M derived: sum of 2 quarters · filed 2026-05-07 | -$30.44M derived: sum of 3 quarters · filed 2026-05-07 | $7.51M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $57.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $221.92M derived: sum of 2 quarters · filed 2026-02-26 | $259.87M derived: sum of 3 quarters · filed 2026-08-03 | $173.91M 10-K · filed 2026-02-26 |
| 2025-09-30 | $164.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $202.76M derived: sum of 2 quarters · filed 2026-08-03 | $116.80M 10-Q · filed 2025-11-06 | -$425.29M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $37.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$48.01M 10-Q · filed 2026-08-03 | -$590.10M derived: sum of 3 quarters · filed 2026-08-03 | -$569.49M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$85.96M 10-Q · filed 2026-05-07 | -$628.05M derived: sum of 2 quarters · filed 2026-05-07 | -$607.45M derived: sum of 3 quarters · filed 2026-05-07 | -$661.09M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$542.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$521.49M derived: sum of 2 quarters · filed 2026-02-26 | -$575.13M derived: sum of 3 quarters · filed 2026-02-26 | -$574.82M 10-K · filed 2026-02-26 |
| 2024-09-30 | $20.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$33.04M derived: sum of 2 quarters · filed 2025-11-06 | -$32.73M 10-Q · filed 2025-11-06 | -$120.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$53.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$53.33M 10-Q · filed 2025-08-07 | -$140.64M derived: sum of 3 quarters · filed 2026-02-26 | -$333.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $309.00K 10-Q · filed 2025-05-08 | -$87.00M derived: sum of 2 quarters · filed 2026-02-26 | -$280.30M derived: sum of 3 quarters · filed 2026-02-26 | -$248.86M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$87.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$280.60M derived: sum of 2 quarters · filed 2026-02-26 | -$249.17M derived: sum of 3 quarters · filed 2026-02-26 | -$200.41M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$193.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$161.86M derived: sum of 2 quarters · filed 2024-11-12 | -$113.11M 10-Q · filed 2024-11-12 | -$76.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $31.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $80.19M 10-Q · filed 2024-08-08 | $117.04M derived: sum of 3 quarters · filed 2025-02-27 | $123.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $48.76M 10-Q · filed 2024-05-09 | $85.61M derived: sum of 2 quarters · filed 2025-02-27 | $92.43M derived: sum of 3 quarters · filed 2025-02-27 | -$81.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $36.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $43.67M derived: sum of 2 quarters · filed 2025-02-27 | -$130.60M derived: sum of 3 quarters · filed 2025-02-27 | -$173.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$167.45M derived: sum of 2 quarters · filed 2023-11-07 | -$210.83M 10-Q · filed 2023-11-07 | -$312.63M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$174.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$217.66M 10-Q · filed 2023-08-08 | -$319.45M derived: sum of 3 quarters · filed 2024-02-28 | -$326.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$43.38M 10-Q · filed 2023-05-09 | -$145.18M derived: sum of 2 quarters · filed 2024-02-28 | -$152.21M derived: sum of 3 quarters · filed 2024-02-28 | -$132.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$101.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$108.82M derived: sum of 2 quarters · filed 2024-02-28 | -$88.98M derived: sum of 3 quarters · filed 2024-02-28 | -$56.48M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $12.81M derived: sum of 2 quarters · filed 2022-11-14 | $45.31M 10-Q · filed 2022-11-14 | $36.42M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $19.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $52.34M 10-Q · filed 2022-08-12 | $43.45M derived: sum of 3 quarters · filed 2023-02-28 | $18.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $32.50M 10-Q · filed 2022-05-12 | $23.61M derived: sum of 2 quarters · filed 2023-02-28 | -$1.22M derived: sum of 3 quarters · filed 2023-02-28 | $16.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$33.72M derived: sum of 2 quarters · filed 2023-02-28 | -$16.12M derived: sum of 3 quarters · filed 2023-02-28 | $217.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | -$24.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$7.23M derived: sum of 2 quarters · filed 2021-11-05 | $9.11M 10-Q · filed 2021-11-05 | -$3.71M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | $17.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $33.94M 10-Q · filed 2021-08-10 | $21.12M derived: sum of 3 quarters · filed 2022-03-30 | $41.57M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | $16.34M 10-Q · filed 2021-05-06 | $3.52M derived: sum of 2 quarters · filed 2022-03-30 | $23.96M derived: sum of 3 quarters · filed 2022-03-30 | $33.41M derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | -$12.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $7.63M derived: sum of 2 quarters · filed 2022-03-30 | $17.07M derived: sum of 3 quarters · filed 2022-03-30 | $41.67M 10-K · filed 2022-03-30 |
| 2019-09-30 | $20.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $29.89M derived: sum of 2 quarters · filed 2020-11-06 | $54.49M 10-Q · filed 2020-11-06 | -$64.19M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $9.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $34.04M 10-Q · filed 2020-08-07 | -$84.64M derived: sum of 3 quarters · filed 2021-03-30 | -$84.89M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | $24.60M 10-Q · filed 2020-05-08 | -$94.08M derived: sum of 2 quarters · filed 2021-03-30 | -$94.33M derived: sum of 3 quarters · filed 2021-03-30 | -$94.80M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | -$118.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$118.93M derived: sum of 2 quarters · filed 2021-03-30 | -$119.40M derived: sum of 3 quarters · filed 2021-03-30 | -$119.46M 10-K · filed 2021-03-30 |
| 2018-09-30 | -$251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$720.00K derived: sum of 2 quarters · filed 2019-11-12 | -$777.00K 10-Q · filed 2019-11-12 | -$1.01M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | -$469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$526.00K 10-Q · filed 2019-08-13 | -$757.00K derived: sum of 3 quarters · filed 2020-03-09 | -$775.00K derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | -$57.00K 10-Q · filed 2019-05-13 | -$288.00K derived: sum of 2 quarters · filed 2020-03-09 | -$306.00K derived: sum of 3 quarters · filed 2020-03-09 | |
| 2017-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$249.00K derived: sum of 2 quarters · filed 2020-03-09 | -$304.00K 10-K · filed 2020-03-09 | |
| 2017-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$73.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$55.00K 10-Q · filed 2018-08-30 | |||
| 2016-12-31 | -$190.00K 10-K · filed 2019-03-13 |